DR. GREGORY ASHTON EDWARDS M.D. NPI 1700853793

NPI Details

DR. Gregory Ashton Edwards, M.D. is an urology in Longview, TX with 29 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. DR. Gregory Ashton Edwards, M.D. NPI is 1700853793. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN NEW ORLEANS
Graduation Year:1997

The provider's business location address is:

802 MEDICAL DR
SUITE 400
LONGVIEW, TX
ZIP 75605-100
Phone: (903) 757-7871
Fax: (903) 753-2479

The NPI 1700853793 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Ultrasonic guidance for administration of radiation therapy (HCPCS:76965)
• Insertion of needle or tube into prostate for radiation therapy (HCPCS:55875)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Imaging of urinary tract following injection of a contrast agent (HCPCS:74420)
• Ultrasound scan of prostate through rectum (HCPCS:76873)
• Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
• Biopsy of prostate gland (HCPCS:55700)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 3/8/2006 and was last updated on 12/23/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.